Vertebral body mesenchymal stem cells derived from whole bone marrow aspirate may provide alternative stem cell sources for spine surgery applications, according to a study in Spine.
Biologics
LifeNet Health launched the PliaFX Prime allograft surgical solution.
Cellect Biotechnology's ApoGraft technology demonstrated positive results for orthopedic applications in a study.
Kuros Biosciences submitted an FDA 510(k) clearance regulatory package for its Fibrin-PTH (KUR-113).
Reinvent Biologics is a regenerative medicine company.
Advertisement
Platelet-rich plasma injections and stem cell therapies are ushering in a "new dawn" in orthopedics, according to Jason Arora, DO, a board-certified interventional spine and pain management physician at West Orange, N.J.-based Atlantic Spine Center.
Cynata Therapeutics entered into a licensing agreement with Fujifilm Holdings to begin stem cell therapy clinical trials in the U.S. and Japan, according to Nikkei Asian Review.
New York City-based Hospital for Special Surgery researchers launched a clinical trial to assess the effects of Organogenesis' ReNu on knee function.
A stem cell provider registry program will improve the quality of treatments, wrote Fabio Rossi, MD, PhD, and Judy Illes, PhD, in an op-ed in the Vancouver Sun.
Baxter International received FDA 510(k) clearance for its Altapore Bioactive Bone Graft for spinal fusion.